EVALUATING THE CLINICAL AND HEMODYNAMICAL ACTION OF NEBIVOLOL IN CHRONIC HEART FAILURE
A task of this research was to study the influence of nebivolol on hemodynamic parameters, clinical sympthoms and life quality in patients II-IV FK HD by NYHA. 24 patients of main group have taken nebivolol in daily dose of 2,5-5 mg per os. Patients were treated with the drug in a course of 3 months...
Saved in:
| Main Authors: | M. A. Gurevich, N. P. Sanina, T. F. Hohlova, V. I. Buvalcev |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
«FIRMA «SILICEA» LLC
2001-04-01
|
| Series: | Российский кардиологический журнал |
| Subjects: | |
| Online Access: | https://russjcardiol.elpub.ru/jour/article/view/2148 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
NEBIVOLOL ROLE IN THE CORRECTION OF INTRACARDIAC HEMODYNAMICS IN PATIENTS WITH CHRONIC HEART FAILURE
by: R. L. Dzhanaeva, et al.
Published: (2012-02-01) -
COMPUTER MODELING IN THE DEVELOPMENT OF ARTIFICIAL VENTRICLES OF HEART
by: L. V. Belyaev, et al.
Published: (2011-12-01) -
THE INFLUENCE OF INDAPAMIDE ON BLOOD PRESSURE DAILY PROFILE, HEMODYNAMICS AND RENIN-ANGIOTENSIN-ALDOSTERONE SYSTEM IN HYPERTENSIVE PATIENTS OLDER THAN 55 YEARS
by: S. V. Shlyk, et al.
Published: (2002-02-01) -
Sex-related differences in the acute physiological response to a high-intensity CrossFit® workout
by: Manoel Rios, et al.
Published: (2025-01-01) -
Clinical efficacy of nebivolol and metoprolol in complex treatment of patients with coronary heart disease and II-III functional class chronic heart failure
by: A. G. Evdokimova, et al.
Published: (2005-04-01)